What is Leerink Partnrs’ Forecast for ABCL Q1 Earnings?
AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) – Analysts at Leerink Partnrs issued their Q1 2026 earnings per share (EPS) estimates for shares of AbCellera Biologics in a report released on Wednesday, April 16th. Leerink Partnrs analyst P. Souda anticipates that the company will post earnings per share of ($0.16) for the quarter. The consensus […]
More Stories
Amazon to Hire 300,000 US Workers for Holiday Season
By Andrew Moran Amazon has posted a help-wanted sign for this year’s holiday season. The online retailer said on Oct....
Trump Launches $25 Million Fraud Whistleblower Program, Offering Cash for Tips
By Emel Akan WASHINGTON—President Donald Trump and Vice President JD Vance announced on Tuesday the launch of a $25 million...
US, Partners Seize Nearly 1,500 Pounds of Cocaine in the Caribbean
By Naveen Athrappully A U.S. task force and foreign partners seized nearly 1,500 pounds of cocaine in two operations in...
European Union Unveils Arctic Strategy Aimed at Strengthening Security
By Victoria Friedman The European Union (EU) has unveiled plans to boost security in the Arctic that include better threat...
DOJ Charges 28 Noncitizens in California With Election Crimes
By Tom Gantert The Justice Department announced on Oct. 19 that 28 noncitizens living in California face election-related criminal charges,...
Homebuilder Confidence Drops in October Amid Weak Demand, Rising Costs
By Bill Pan Confidence among U.S. homebuilders fell in October, as rising mortgage rates discouraged buyers while construction costs and...